New technology for an old favorite: lentiviral transgenesis and RNAi in rats
- PMID: 17682833
- DOI: 10.1007/s11248-007-9121-z
New technology for an old favorite: lentiviral transgenesis and RNAi in rats
Abstract
The ability to produce targeted deletions in the mouse genome via homologous recombination has been a hallmark of mouse genetics, and has lead to the production of thousands of gene knockouts. New technologies are making it possible to disrupt gene function in many other species. This article reviews some of these methods, highlighting the powerful combination of lentiviral vectors with RNA interference (RNAi), which allows one to produce transgenic animals expressing short hairpin RNA (shRNA) to "knock down" specific gene expression. Lentiviral transduction of embryos has been shown to be a highly efficient means of transgenesis, and is particularly promising for animals that are considered difficult to genetically modify by DNA pronuclear injection. This technique has been popular for introducing transgenes for shRNA expression into rodents and its utility for creating new genetic models has already been demonstrated. One of the purported advantages of in vivo RNAi is that shRNA expressing transgenes would be expected to act in a dominant nature, resulting in a phenotype in founder animals. However, one possible concern with lentiviral-mediated transgenesis is the potential for mosaicism in founders, and the data for this phenomenon and the potential causes and solutions are discussed. Emphasis is placed on the application of in vivo RNAi, and other reverse genetic methods, for creating new genetic models in the rat.
Similar articles
-
Production of knockdown rats by lentiviral transduction of embryos with short hairpin RNA transgenes.Methods Mol Biol. 2008;450:193-209. doi: 10.1007/978-1-60327-214-8_14. Methods Mol Biol. 2008. PMID: 18370061
-
Lentiviral transgenesis.Methods Mol Biol. 2009;530:391-405. doi: 10.1007/978-1-59745-471-1_21. Methods Mol Biol. 2009. PMID: 19266335
-
Lentiviral vectors: are they the future of animal transgenesis?Physiol Genomics. 2007 Oct 22;31(2):159-73. doi: 10.1152/physiolgenomics.00069.2007. Epub 2007 Aug 7. Physiol Genomics. 2007. PMID: 17684037 Review.
-
Lentiviral transgenesis--a versatile tool for basic research and gene therapy.Curr Gene Ther. 2006 Aug;6(4):535-42. doi: 10.2174/156652306777934856. Curr Gene Ther. 2006. PMID: 16918338
-
Applications of lentiviral vectors for shRNA delivery and transgenesis.Curr Gene Ther. 2008 Dec;8(6):483-8. doi: 10.2174/156652308786848067. Curr Gene Ther. 2008. PMID: 19075631 Free PMC article. Review.
Cited by
-
Generation and characterization of a Tet-On (rtTA-M2) transgenic rat.BMC Dev Biol. 2010 Feb 16;10:17. doi: 10.1186/1471-213X-10-17. BMC Dev Biol. 2010. PMID: 20158911 Free PMC article.
-
Variegation and silencing in a lentiviral-based murine transgenic model.Transgenic Res. 2010 Jun;19(3):399-414. doi: 10.1007/s11248-009-9318-4. Epub 2009 Aug 23. Transgenic Res. 2010. PMID: 19701794
-
Methylation silencing and reactivation of exogenous genes in lentivirus-mediated transgenic mice.Transgenic Res. 2021 Feb;30(1):63-76. doi: 10.1007/s11248-020-00224-9. Epub 2021 Jan 4. Transgenic Res. 2021. PMID: 33394315
-
A construct with fluorescent indicators for conditional expression of miRNA.BMC Biotechnol. 2008 Oct 7;8:77. doi: 10.1186/1472-6750-8-77. BMC Biotechnol. 2008. PMID: 18840295 Free PMC article.
-
Lentiviral short hairpin RNA screen of genes associated with multidrug resistance identifies PRP-4 as a new regulator of chemoresistance in human ovarian cancer.Mol Cancer Ther. 2008 Aug;7(8):2377-85. doi: 10.1158/1535-7163.MCT-08-0316. Epub 2008 Aug 7. Mol Cancer Ther. 2008. PMID: 18687998 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources